Patient-reported symptom and functioning status during the first 12 months after CAR T-cell therapy for hematological malignancies.

Wang XShelley, Srour SA, Whisenant M, Subbiah I, Chen THsuan, Ponce D, Gonzalez AGarcia, Kamal M, Mendoza T, Cleeland C, et al. Patient-reported symptom and functioning status during the first 12 months after CAR T-cell therapy for hematological malignancies. Transplant Cell Ther. 2021.